7F1M image
Deposition Date 2021-06-09
Release Date 2022-03-09
Last Version Date 2024-06-12
Entry Detail
PDB ID:
7F1M
Keywords:
Title:
Marburg virus nucleoprotein-RNA complex
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
Aggregation State:
HELICAL ARRAY
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Nucleoprotein
Gene (Uniprot):NP
Mutations:H198Y, H330Y
Chain IDs:A, C (auth: B)
Chain Length:395
Number of Molecules:2
Biological Source:Lake Victoria marburgvirus (strain Angola/2005)
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*UP*UP*UP*UP*UP*U)-3')
Chain IDs:B (auth: R), D (auth: S)
Chain Length:6
Number of Molecules:2
Biological Source:synthetic construct
Primary Citation
Structural insight into Marburg virus nucleoprotein-RNA complex formation.
Nat Commun 13 1191 1191 (2022)
PMID: 35246537 DOI: 10.1038/s41467-022-28802-x

Abstact

The nucleoprotein (NP) of Marburg virus (MARV), a close relative of Ebola virus (EBOV), encapsidates the single-stranded, negative-sense viral genomic RNA (vRNA) to form the helical NP-RNA complex. The NP-RNA complex constitutes the core structure for the assembly of the nucleocapsid that is responsible for viral RNA synthesis. Although appropriate interactions among NPs and RNA are required for the formation of nucleocapsid, the structural basis of the helical assembly remains largely elusive. Here, we show the structure of the MARV NP-RNA complex determined using cryo-electron microscopy at a resolution of 3.1 Å. The structures of the asymmetric unit, a complex of an NP and six RNA nucleotides, was very similar to that of EBOV, suggesting that both viruses share common mechanisms for the nucleocapsid formation. Structure-based mutational analysis of both MARV and EBOV NPs identified key residues for helical assembly and subsequent viral RNA synthesis. Importantly, most of the residues identified were conserved in both viruses. These findings provide a structural basis for understanding the nucleocapsid formation and contribute to the development of novel antivirals against MARV and EBOV.

Legend

Protein

Chemical

Disease

Primary Citation of related structures